Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple MyelomaNeha Korde, Ola Landgren, Candis Morrison et al.|JAMA Oncology|2015Cited by 309
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disordersMarco Ladetto, Christiane Pott, Monika Brüggemann et al.|Leukemia|2013Cited by 305
Detection of circulating tumour <scp>DNA</scp> in patients with aggressive B‐cell non‐Hodgkin lymphomaPhilippe Armand, Arnold S. Freedman, Yasuhiro Oki et al.|British Journal of Haematology|2013Cited by 72
A phase 2 study of Rituximab‐Bendamustine and Rituximab‐Cytarabine for transplant‐eligible patients with mantle cell lymphomaPhilippe Armand, Eric D. Jacobsen, Robert Redd et al.|British Journal of Haematology|2016Cited by 68
Next-Generation Sequencing and Real-Time Quantitative PCR for Minimal Residual Disease (MRD) Detection Using the Immunoglobulin Heavy Chain Variable Region: A Methodical Comparison in Acute Lymphoblastic Leukemia (ALL), Mantle Cell Lymphoma (MCL) and Multiple Myeloma (MM)Marco Ladetto, Christiane Pott, Monika Brüggemann et al.|Blood|2012Cited by 6